United States · Platforms & data · MarketBeat
What NeoGenomics (NEO) Said on Its Q3 Earnings Call
NeoGenomics (NASDAQ:NEO) reported third-quarter revenue growth of 11% year over year, led by continued expansion in next-generation sequencing, or NGS, testing, while raising its…
Read the full article on MarketBeat Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)



